Total Payments
$56,390
2024 Payments
$60.97
Companies
15
Transactions
229
Medicare Patients
2,434
Medicare Billing
$257,572
Payment Breakdown by Category
Research$52,424 (93.0%)
Food & Beverage$3,060 (5.4%)
Travel$889.12 (1.6%)
Education$16.44 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $52,424 | 32 | 93.0% |
| Food and Beverage | $3,060 | 192 | 5.4% |
| Travel and Lodging | $889.12 | 3 | 1.6% |
| Education | $16.44 | 2 | 0.0% |
Payments by Type
Research
$52,424
32 transactions
General
$3,965
197 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk AS | $53,717 | 36 | $0 (2020) |
| Novo Nordisk Inc | $602.43 | 44 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $438.12 | 28 | $0 (2021) |
| Lilly USA, LLC | $411.19 | 29 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $403.00 | 34 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $234.61 | 17 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $151.04 | 11 | $0 (2020) |
| Abbott Laboratories | $135.02 | 9 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $94.42 | 7 | $0 (2019) |
| Insulet Corporation | $89.91 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $60.97 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($46.63) |
| 2023 | $182.49 | 12 | Lilly USA, LLC ($45.46) |
| 2022 | $155.90 | 10 | SANOFI-AVENTIS U.S. LLC ($54.48) |
| 2021 | $24.25 | 2 | AstraZeneca Pharmaceuticals LP ($24.25) |
| 2020 | $16,761 | 23 | Novo Nordisk AS ($16,590) |
| 2019 | $36,463 | 69 | Novo Nordisk AS ($35,835) |
| 2018 | $687.77 | 55 | Novo Nordisk Inc ($191.90) |
| 2017 | $2,055 | 54 | Novo Nordisk AS ($1,293) |
All Payment Transactions
229 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: DIABETES | ||||||
| 04/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: DIABETES | ||||||
| 02/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes Care | ||||||
| 01/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: DIABETES | ||||||
| 10/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: DIABETES | ||||||
| 08/11/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Diabetes Care | ||||||
| 08/10/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: DIABETES | ||||||
| 04/13/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Diabetes Care | ||||||
| 04/12/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Diabetes | ||||||
| 04/06/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/06/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Endocrinology | ||||||
| 02/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: DIABETES | ||||||
| 02/08/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/30/2023 | Lilly USA, LLC | LYUMJEV (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Diabetes | ||||||
| 01/26/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $14.46 | General |
| Category: Insulin Pump | ||||||
| 01/11/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Diabetes | ||||||
| 11/28/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Diabetes Care | ||||||
| 11/07/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/02/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Diabetes Care | ||||||
| 09/26/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/27/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/11/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes Care | ||||||
| 06/02/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 05/25/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: Diabetes | ||||||
| 04/26/2022 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Insulin Pump | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN9536-4374 | Novo Nordisk AS | $52,424 | 32 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 572 | 1,655 | $105,674 | $64,399 |
| 2022 | 10 | 610 | 1,677 | $111,205 | $69,448 |
| 2021 | 9 | 594 | 1,658 | $102,204 | $68,132 |
| 2020 | 9 | 658 | 1,589 | $91,709 | $55,593 |
Total Patients
2,434
Total Services
6,579
Medicare Billing
$257,572
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 112 | 397 | $60,785 | $37,822 | 62.2% |
| 95926 | Placement of skin electrodes and measurement of stimulated sites in legs | Office | 2023 | 58 | 60 | $12,120 | $7,417 | 61.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 37 | 229 | $12,615 | $6,163 | 48.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 90 | $6,132 | $3,955 | 64.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 108 | 323 | $4,577 | $3,075 | 67.2% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2023 | 13 | 14 | $2,759 | $1,722 | 62.4% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 112 | 401 | $2,304 | $1,544 | 67.0% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 19 | 20 | $2,200 | $1,244 | 56.5% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 17 | 17 | $1,870 | $1,152 | 61.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 59 | 104 | $312.00 | $305.76 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 112 | 405 | $62,075 | $38,623 | 62.2% |
| 95926 | Placement of skin electrodes and measurement of stimulated sites in legs | Office | 2022 | 66 | 67 | $13,532 | $8,970 | 66.3% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 37 | 197 | $10,870 | $5,219 | 48.0% |
| 95925 | Placement of skin electrodes and measurement of stimulated sites in arms | Office | 2022 | 30 | 30 | $7,020 | $4,802 | 68.4% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 110 | 336 | $4,839 | $3,223 | 66.6% |
| 95250 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | Office | 2022 | 18 | 22 | $4,246 | $2,775 | 65.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 30 | 57 | $3,888 | $2,631 | 67.7% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 115 | 418 | $2,433 | $1,622 | 66.7% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2022 | 16 | 16 | $1,880 | $1,200 | 63.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 76 | 129 | $423.00 | $381.99 | 90.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 392 | $57,232 | $39,747 | 69.4% |
| 95926 | Insertion of needles and skin electrodes for measurement and recording of stimulated sites in the legs | Office | 2021 | 67 | 72 | $12,747 | $8,843 | 69.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 79 | $8,137 | $4,869 | 59.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 32 | 167 | $9,185 | $4,589 | 50.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 109 | 339 | $4,879 | $3,292 | 67.5% |
About Dr. John Shelmet, MD
Dr. John Shelmet, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Lawrenceville, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770699480.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Shelmet, MD has received a total of $56,390 in payments from pharmaceutical and medical device companies, with $60.97 received in 2024. These payments were reported across 229 transactions from 15 companies. The most common payment nature is "" ($52,424).
As a Medicare-enrolled provider, Shelmet has provided services to 2,434 Medicare beneficiaries, totaling 6,579 services with total Medicare billing of $257,572. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Lawrenceville, NJ
- Active Since 08/23/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770699480
Products in Payments
- Tresiba (Drug) $1,308
- FARXIGA (Drug) $438.12
- TOUJEO (Drug) $227.71
- Saxenda (Drug) $185.87
- JARDIANCE (Drug) $183.13
- Victoza (Drug) $178.91
- HUMULIN (Drug) $170.99
- JANUVIA (Drug) $151.04
- Ozempic (Drug) $137.01
- TRULICITY (Drug) $109.34
- TOUJEO (Biological) $91.33
- Omnipod (Device) $89.91
- TRADJENTA (Drug) $80.16
- SOLIQUA (Drug) $62.92
- INVOKANA (Drug) $52.10
- FREESTYLE LIBRE 3 (Device) $42.93
- XARELTO (Drug) $42.32
- FreeStyle Libre Pro (Device) $34.02
- FREESTYLE LIBRE 2 (Device) $33.47
- Xultophy 100/3.6 (Drug) $32.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Lawrenceville
Adeniyi Odugbesan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.1M
Endocrinology, Diabetes & Metabolism $1.1M
David Shore, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $69,315
Endocrinology, Diabetes & Metabolism $69,315
David Arkin, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $16,925
Endocrinology, Diabetes & Metabolism $16,925
Aparna Mahakala, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $13,003
Endocrinology, Diabetes & Metabolism $13,003
Ketan Goswami, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $5,740
Endocrinology, Diabetes & Metabolism $5,740
Peter Lu, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $4,213
Endocrinology, Diabetes & Metabolism $4,213